HLMA.L Stock - Halma plc
Unlock GoAI Insights for HLMA.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.25B | $2.03B | $1.85B | $1.53B | $1.32B |
| Gross Profit | $1.13B | $1.01B | $877.90M | $724.30M | $613.60M |
| Gross Margin | 50.4% | 49.7% | 47.4% | 47.5% | 46.5% |
| Operating Income | $409.50M | $367.70M | $321.50M | $284.80M | $252.30M |
| Net Income | $296.40M | $268.80M | $234.50M | $244.40M | $203.40M |
| Net Margin | 13.2% | 13.2% | 12.7% | 16.0% | 15.4% |
| EPS | $0.79 | $0.71 | $0.62 | $0.65 | $0.54 |
Halma plc, through its subsidiaries, provides technology solutions in the safety, health, and environmental markets. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire detection, specialist fire suppression, elevator safety, security sensors, people and vehicle flow technologies, specialized interlocks that control critical processes safely, and explosion protection and corrosion monitoring systems. This segment serves elevator safety, fire suppression, people and vehicle flow, fire detection, pressure management, industrial access control, and safe storage and transfer markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; water, air and gases monitoring technologies; instruments that detect hazardous gases and analyses air quality; and systems for water analysis and treatment. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; laboratory devices and systems that provide information to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable positive outcomes across clinical specialties. This segment serves the life sciences, health assessment, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
Visit WebsiteEarnings History & Surprises
HLMA.LEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 20, 2025 | $0.49 | $0.57 | +16.5% | ✓ BEAT |
Q2 2025 | Jun 11, 2025 | $0.47 | $0.48 | +3.0% | ✓ BEAT |
Q4 2024 | Nov 21, 2024 | $0.45 | $0.46 | +0.6% | ✓ BEAT |
Q2 2024 | Jun 13, 2024 | $0.44 | $0.45 | +3.4% | ✓ BEAT |
Q1 2024 | Mar 21, 2024 | $0.36 | $0.36 | -0.3% | ✗ MISS |
Q2 2023 | Jun 15, 2023 | $0.40 | $0.31 | -20.7% | ✗ MISS |
Q4 2022 | Nov 17, 2022 | $0.35 | $0.30 | -12.7% | ✗ MISS |
Q1 2022 | Mar 31, 2022 | $0.32 | $0.29 | -11.3% | ✗ MISS |
Q3 2021 | Sep 30, 2021 | $0.31 | $0.36 | +15.6% | ✓ BEAT |
Q1 2021 | Mar 31, 2021 | $0.30 | $0.33 | +9.3% | ✓ BEAT |
Q3 2020 | Sep 30, 2020 | $0.22 | $0.20 | -6.2% | ✗ MISS |
Q1 2020 | Mar 31, 2020 | $0.29 | $0.26 | -10.7% | ✗ MISS |
Q3 2019 | Sep 30, 2019 | — | $0.22 | — | — |
Q1 2019 | Mar 31, 2019 | — | $0.25 | — | — |
Q3 2018 | Sep 30, 2018 | — | $0.20 | — | — |
Q1 2018 | Mar 31, 2018 | — | $0.24 | — | — |
Q3 2017 | Sep 30, 2017 | — | $0.16 | — | — |
Q1 2017 | Mar 31, 2017 | — | $0.20 | — | — |
Q4 2016 | Oct 1, 2016 | — | $0.14 | — | — |
Q1 2016 | Mar 31, 2016 | — | $0.15 | — | — |
Latest News
Frequently Asked Questions about HLMA.L
What is HLMA.L's current stock price?
What is the analyst price target for HLMA.L?
What sector is Halma plc in?
What is HLMA.L's market cap?
Does HLMA.L pay dividends?
Similar Stocks
Industrials SectorExplore stocks similar to HLMA.L for comparison